The AMYPOWER ALLTRACK power wheelchair's intended use is to provide mobility to persons limited to a seating position, that have the capability of operating a powered wheelchair. The AMYPOWER ALL TRACK power wheelchair empowers physically challenged individuals by providing a means of mobility.

Device Description

The AMYPOWER ALLTRACK power wheelchair is a battery powered, motor driven device. It is a rigid or "non-folding" type power wheelchair design that offers functionality to be used as a mid wheel drive or a rear wheel drive base. The design offers a modular approach and can be configured in multiple versions to suit different client needs. The ALLTRACK series power wheelchair is designed to offer the ultimate in safety, stability, performance and comfort for the user. It features an active six wheel suspension as well as a seat suspension, and front and rear anti-tip casters which allow for surface contact of all six wheels at all times and prevents pitching on slopped terrain. The ALLTRACK power wheelchair utilizes components typically found on most wheelchairs, including but not limited to a rigid steel frame, a seat, armrests, front riggings, two main drive wheels, two electric drive motors, front & rear castors, two batteries, a charger, a positioning belt and a controller.

AI/ML Overview

The provided text describes the submission for a power wheelchair, which is a medical device. Based on the information provided, this is not a device that relies on algorithms, AI, or specific performance metrics that would require an "acceptance criteria" table in the traditional sense of AI/ML-driven devices.

Instead, the acceptance criteria for this type of device are met through adherence to established industry standards and regulations for safety and functionality. The study that proves the device meets these criteria is the non-clinical testing described in the document.

Here's the breakdown of the requested information based on the provided text:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria	Reported Device Performance
Mechanical/Safety Performance (based on ISO & ANSI/RESNA standards)- Compliance with ISO EMC Standard 7176-14- Compliance with ANSI/RESNA WC vol. 1 & vol. 2, Section 21:1998 amendments for powered wheelchairs and motorized scooters- Functionality for active six-wheel suspension, seat suspension, front and rear anti-tip casters (surface contact of all six wheels, preventing pitching on sloped terrain)	- Met the required performance criteria and functioned as intended in all instances for ISO EMC Standard 7176-14 and ANSI/RESNA WC vol. 1 & vol. 2, Section 21:1998 amendments.- Features an active six-wheel suspension, seat suspension, and front and rear anti-tip casters, allowing for surface contact of all six wheels at all times and preventing pitching on sloped terrain.
Substantial Equivalence to Predicate Devices- Similar intended use- Similar technological characteristics (materials, controls, power source, operating speeds, maneuverability, power modules, hand controls, seat types, drive wheels, climbing ability, standard accessories)	- Demonstrated to be substantially equivalent to the predicate devices (Invacare Storm TDX K023589, Invacare Storm K940051) in terms of meeting performance criteria and functioning as intended.- Differences in technological characteristics do not raise any concerns of safety or effectiveness.
Safety for User Operation	- Considered to be safe for user operation.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Sample Size: Not explicitly stated as a number of individual units. The testing involved "the AMYPOWER ALLTRACK series power wheelchair," implying potentially one or a representative sample of units undergoing the specified non-clinical tests.
Data Provenance: The testing was conducted in accordance with international and North American standards (ISO & ANSI/RESNA). The manufacturer, Amylior Inc., is based in Quebec, Canada, suggesting the testing likely occurred to satisfy Canadian and US regulatory requirements for market clearance. The data is based on non-clinical testing, which is a prospective assessment of the device's physical performance characteristics against defined standards.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This information is not applicable as the "ground truth" for this device is established by objective engineering and safety standards (ISO, ANSI/RESNA), not by expert consensus on clinical data interpretation. The evaluation is against measurable physical properties and functional requirements.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. Adjudication methods like "2+1" typically apply to cases where multiple human readers are interpreting complex data (e.g., medical images) and their disagreements need to be resolved by a third party. For a power wheelchair's non-clinical safety and performance testing, the results are objectively measured against established criteria; there is no subjective interpretation requiring adjudication.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is a mechanical power wheelchair, not an AI/ML-driven diagnostic or assistive device that would involve human readers or comparative effectiveness studies with AI assistance.

6. If a standalone (i.e. algorithm only, without human-in-the-loop performance) was done

Not applicable. This device is a mechanical power wheelchair and does not contain artificial intelligence algorithms. Its performance is inherent in its design and construction, and validated through physical testing against standards.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The ground truth is based on established international and national engineering, safety, and performance standards (ISO EMC Standard 7176-14 and ANSI/RESNA WC vol. 1 & vol. 2, Section 21:1998 amendments). Compliance with these objective standards serves as the "ground truth" for device acceptability.

8. The sample size for the training set

Not applicable. This device is a mechanical power wheelchair; it does not involve machine learning or a "training set" in the context of AI/ML models.

9. How the ground truth for the training set was established

Not applicable. As stated above, there is no training set for this type of device.

Summary

{0}------------------------------------------------

K092225

510(k) Summary 510(k) Premarket NotificationCT - 9 2009

Administrative Information and Device Identification

Name and address of the manufacturer and sponsor of the 510(k) submission: Amylior Inc. 1650 Chicoine Vaudreuil-Dorion, Quebec, Canada J7V 8P2

FDA registration number of the manufacturer of the new device: 9615410

Official contact person for all correspondence:

Eric Dugas President Amylior Inc. 1650 Chicoine Vaudreuil-Dorion, Quebec, Canada J7V 8P2 Phone: 450-424-0288 Ext:223 Fax: 450-424-7211 Email: edugas@amysystems.com

Date Prepared: July 20th, 2009

Device Name: AMYPOWER ALLTRACK Series Power Wheelchair

Generic name of the device: Power Wheelchair

Classification of the predicate device: Class II

Classification of new device: Class II

Classification Panel: Physical Medicine

Panel Code: ITI

CFR Regulation Number: 21 CFR 890.3860

Predicate Device Name(s) and 510(k) number(s): Invacare Corporations' Storm TDX power wheelchair (K023589, 11/19/2002), and Invacare Storm Power wheelchair (K940051, 03/28/1994).

Summary page 1 of 3

{1}------------------------------------------------

Description of Device:

Comparison of Device Technological Characteristics to Predicate Devices:

This device has similar technological characteristics as the predicate devices. They all use steel and aluminum in their frames and components, and standard foams and covers for the slings, backs and cushions. The end-user controls the chair by using a iovstick or other equivalent command mode through a controller. Motors use 2 x 12 volt DC rechargeable batteries as a source of energy. The operating speeds, maneuverability, power modules, hand controls, seat types, drive wheels, and climbing ability are substantially equivalent and are recommended for indoor and moderate outdoor use. The standard accessories and components are common to all power wheel chair devices.

Statement of Intended Use:

The intended use of the Amylior Inc. model AMYPOWER ALLTRACK series power wheelchair and other predicate devices is to provide mobility to persons limited to a sitting position, that have the capability of operating a powered wheelchair. The AMYPOWER ALLTRACK series power wheelchair provides an optional means of mobility for physically challenged people.

Summary page 2 of 3

{2}------------------------------------------------

Non-Clinical Testing:

This device has been tested to appropriate ISO & ANSVRESNA standards and other applicable requirements passing all test protocols. As required by FDA's July 26, 1995 draft publication entitled "Guidance Document for the Preparation of Premarket Notification [510(k)] Applications for Mechanical and Powered Wheelchairs, and Motorized Three-Wheeled Vehicles", the AMYPOWER ALLTRACK series power wheelchair was tested in accordance with ISO EMC Standard 7176-14 and ANSI/RESNA WC vol. 1 & vol. 2, Section 21:1998 amendments for powered wheelchairs and motorized scooters. In all instances, the AMYPOWER ALLTRACK series power wheelchair met the required performance criteria and functioned as intended.

Statement of Safety and Effectiveness:

Analysis of comparison of design, function and features of the AMYPOWER ALLTRACK series power wheelchair to the Invacare Storm TDX power wheelchair (K023589, 11/19/2002), and Invacare Storm Power wheelchair (K940051, 03/28/1994), together with the results of testing demonstrates the device to be substantially equivalent to the predicate devices in terms of meeting performance criteria and functioning as intended.

Conclusion:

The AMYPOWER ALLTRACK series power wheelchair has the same intended use and similar technological characteristics as the Invacare Storm TDX power wheelchair (K023589, 11/19/2002), and Invacare Storm Power wheelchair (K940051, 03/28/1994), moreover, the non-clinical testing and the predicate comparisons demonstrate that any differences in their technological characteristics do not raise any concerns of safety or effectiveness. Thus, the AMYPOWER ALLTRACK series power wheelchair is substantially equivalent to the predicate devices. The AMYPOWER ALLTRACK series power wheelchair has passed all the necessary testing procedures and is considered to be safe for user operation.

{3}------------------------------------------------

Image /page/3/Picture/0 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized eagle or bird-like symbol with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002

Amylior Inc. % Mr. Eric Dugas President 1650 Chicoine Vaudreuil-Dorian Quebec Canda J7V 8P2

OCT - 9 2009

Re: K092225

Trade/Device Name: AMYPOWER ALL TRACK scries power wheechair Regulation Number: 21 CFR 890.3860 Regulation Name: Powered wheelchair Regulatory Class: II Product Code: ITI Dated: August 27, 2009 Received: August 27, 2009

Dear Mr. Dugas:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807): labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 - Mr. Eric Dugas

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Mark N. Melkerso Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use Statement

` 510(k) Number (if known):

Device Name:

AMYPOWER ALLTRACK series power wheelchain

Indications for Use:

The AMYPOWER ALL TRACK power wheelchair's intended use is to provide mobility to persons limited to a seating position, that have the capability of operating a powered wheelchair. The AMYPOWER ALL TRACK power wheelchair empowers physically challenged individuals by
nroviding a moons of mobility providing a means of mobility.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

FOR M..MELKERSON

(Division Sign-Off) Division of Surgical, Orthopedic, . 1 Restorative Devices
510(k) Number K092225

Regulation Number and Section

§ 890.3860 Powered wheelchair.

(a)
Identification. A powered wheelchair is a battery-operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.(b)
Classification. Class II (performance standards).